In this on-demand webinar, learn about the use of Sanger sequencing and fragment analysis across a broad range of applications, from confirmation of sequences during molecular biology applications and gene editing to sample and cell line authentication and manufacturing quality control (QC) and including the recent application in mRNA vaccine identity testing.

In the webinar, Edgar Schreiber, PhD, discusses:

• The use of Sanger sequencing and fragment analysis in drug discovery and development applications including CRISPR confirmation, next generation sequencing (NGS) library QC, sample and cell line authentication, and SNP genotyping
• Data showing the use of capillary electrophoresis (CE)-based sequencing and fragment analysis in late stage development and manufacturing QC, including RNA therapeutic sequence identity analysis and microbial contaminate testing
• The benefits of the latest generation of CE based genetic analyzers, the Applied Biosystems SeqStudio Flex system, in a biopharmaceutical setting

Speaker: